| Melissa Ann Mayo, MOTR/L | |
|
1000 Association Dr, Charleston, WV 25311-1270 | |
| (304) 347-4372 | |
| Not Available |
| Full Name | Melissa Ann Mayo |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1000 Association Dr, Charleston, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851633697 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 1136 (West Virginia) | Primary |
| Provider Name | Wv Therapy Services Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1063692333 PECOS PAC ID: 8123106416 Enrollment ID: O20080428000417 |
News Archive
Low back pain is one of the most common causes of job-related disabilities, influencing employee productivity and ultimately significantly impacting the economic well-being of a business. A pilot study by researchers at the Stanford University School of Medicine examined whether access to the sit-stand workstations could help reduce or relieve chronic low back pain in office workers.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV). The trial, run in centers in Australia and New Zealand, will investigate the antiviral effect of clemizole monotherapy in the absence of interferon.
You've heard the alarming statistic before: one-third of U.S. children and teens are overweight or obese, increasing their risk of developing health problems such as diabetes.
So far, based on clinical data, patients with cystic fibrosis (CF) don't appear to be especially susceptible to COVID-19, and when they do get infected, they don't seem to get sicker. But Ruobing (Ruby) Wang, MD, a physician-scientist in the Division of Pulmonary Medicine at Boston Children's Hospital, cares for patients with CF and thinks there is more to the story.
Celldex Therapeutics, Inc. today presented positive results from the Company's randomized, double‐blind Phase 2 study of RINTEGA (rindopepimut) in patients with EGFRvIII‐positive, recurrent glioblastoma at the 2015 American Society of Clinical Oncology in Chicago.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Ann Mayo, MOTR/L 1000 Association Dr, Charleston, WV 25311-1270 Ph: (304) 347-4372 | Melissa Ann Mayo, MOTR/L 1000 Association Dr, Charleston, WV 25311-1270 Ph: (304) 347-4372 |
News Archive
Low back pain is one of the most common causes of job-related disabilities, influencing employee productivity and ultimately significantly impacting the economic well-being of a business. A pilot study by researchers at the Stanford University School of Medicine examined whether access to the sit-stand workstations could help reduce or relieve chronic low back pain in office workers.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV). The trial, run in centers in Australia and New Zealand, will investigate the antiviral effect of clemizole monotherapy in the absence of interferon.
You've heard the alarming statistic before: one-third of U.S. children and teens are overweight or obese, increasing their risk of developing health problems such as diabetes.
So far, based on clinical data, patients with cystic fibrosis (CF) don't appear to be especially susceptible to COVID-19, and when they do get infected, they don't seem to get sicker. But Ruobing (Ruby) Wang, MD, a physician-scientist in the Division of Pulmonary Medicine at Boston Children's Hospital, cares for patients with CF and thinks there is more to the story.
Celldex Therapeutics, Inc. today presented positive results from the Company's randomized, double‐blind Phase 2 study of RINTEGA (rindopepimut) in patients with EGFRvIII‐positive, recurrent glioblastoma at the 2015 American Society of Clinical Oncology in Chicago.
› Verified 7 days ago
Shanna Marie Ison, OTRL Occupational Therapist Medicare: Medicare Enrolled Practice Location: 699 S Park Rd, Charleston, WV 25304 Phone: 304-925-1532 Fax: 304-926-8018 | |
Ms. Erin Elizabeth Burgess, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 801 Peyton Way, Charleston, WV 25309 Phone: 304-693-2060 | |
Mrs. Amy Ellen Lawrence, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 113 Lakeview Dr, Charleston, WV 25313 Phone: 304-342-9515 | |
Elizabeth Ververeli, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 313 Maccorkle Ave Sw Ste 100, Charleston, WV 25303 Phone: 304-746-3704 | |
Erica Dawn Barker, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 119 Angel Ter, Charleston, WV 25314 Phone: 304-550-6670 | |
Mr. David Kyle Stickel, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 700 Chappell Rd, Charleston, WV 25304 Phone: 304-343-1950 | |
Casey Jo Townsend, MOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 400 Tracy Way, Charleston, WV 25311 Phone: 304-720-0205 |